Literature DB >> 2278825

Interleukin-1 and -2 in sera of patients with chronic hepatitis (type B).

T Ozeki1, K Imanishi, H Unoki, K Funakoshi, Y Kiya.   

Abstract

IL-1 beta and IL-2 values in serum from 28 patients with chronic hepatitis B diagnosed by liver biopsy and 23 healthy controls were measured by the radioimmunoassay (RIA) method. Though both values in patients seropositive for anti-HBe were slightly higher than those in patients seropositive for HBeAg, the differences between the two groups were not statistically significant. In contrast, the relationship between IL-1 beta and IL-2 in patients with chronic hepatitis was statistically significant (P less than 0.001). In general, high values of serum IL-1 beta and IL-2 were seen in patients with chronic persistent hepatitis and low values of serum IL-1 beta and IL-2 were seen in patients with chronic active hepatitis (severe) and in some of these with chronic persistent hepatitis. Serum IL-1 beta and IL-2 values of all patients with chronic hepatitis were higher than in healthy controls (P less than 0.001). Serum IL-1 beta and IL-2 in chronic hepatitis (B) are important indicators of the grade of the inflammatory state of the liver.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2278825      PMCID: PMC2002380     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  7 in total

1.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

2.  Inducer and suppressor T-cells in hepatitis B virus-induced liver disease.

Authors:  H C Thomas; D Brown; G Routhier; G Janossy; P C Kung; G Goldstein; S Sherlock
Journal:  Hepatology       Date:  1982 Mar-Apr       Impact factor: 17.425

3.  Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.

Authors:  K Yoshioka; S Kakumu; H Murakami; K Fukui
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

Review 4.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

5.  Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses.

Authors:  W L Farrar; S B Mizel; J J Farrar
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

6.  Immunocytochemical detection of interleukin 1 within stimulated human monocytes.

Authors:  E K Bayne; E A Rupp; G Limjuco; J Chin; J A Schmidt
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

7.  Monoclonal antibody directed against interleukin 2. I. Inhibition of T lymphocyte mitogenesis and the in vitro differentiation of alloreactive cytolytic T cells.

Authors:  S Gillis; A E Gillis; C S Henney
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.